Evidence map›Paper›PMID 26082512›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Editorial Commentary: Another Call to Cure Hepatitis B.

Ashwin Balagopal, Chloe L Thio

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Ashwin BalagopalDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland.
Chloe L ThioDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland.

Funding

The Progression of Hepatitis C Among IDUs with HIVR01DA016078 · NIDA · JOHNS HOPKINS UNIVERSITY · PI BALAGOPAL, ASHWIN, THOMAS, DAVID L · 2002 to 2016
$10.9M
HBV Response to Tenofovir or Lamivudine-Based ART in HIV-HBV Co-Infected ChineseR01AI106586 · NIAID · JOHNS HOPKINS UNIVERSITY · PI THIO, CHLOE L · 2013 to 2015
$588k
NIAID NIH HHS R01 AI106586NIDA NIH HHS R01 DA016078
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoinfectionAntiviral AgentsHepatitis BHepatitis B virusHepatitis C, ChronicHumansMaleSimeprevirSofosbuvirAntiviral AgentsSimeprevirSofosbuvirHBV-HCV coinfectionHBV reactivationinterferonIP-10ISG

Identifiers

PMID26082512
PMCPMC4583579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.